GHENT, Belgium, June 17, 2021 (GLOBE NEWSWIRE) -- Sequana Medical NV (Euronext Brussels: SEQUA, the "Company" or "Sequana Medical"), an innovator in the treatment of diuretic-resistant fluid overload ...
A fluid that women with advanced ovarian cancer know all too well - ascites, the buildup of liquid in the belly - may be ...
March 13, 2003 — Transjugular intrahepatic portosystemic shunts (TIPS) plus medical therapy is better than medical therapy alone in controlling ascites, but not in improving survival, hospitalization ...
Acceptance and filing review is a first step in the PMA review process Indicates PMA application is sufficiently complete for in-depth review Received in advance of anticipated timing Ghent, Belgium – ...
Sequana Medical is pleased to announce that it has received CE mark approval for use of its alfapump ® system in patients with ascites caused by cancer (malignant ascites). The alfapump ® system was ...
Ghent, Belgium – 23 December 2024 – Sequana Medical NV (Euronext Brussels: SEQUA, the "Company" or "Sequana Medical") , a pioneer in the treatment of drug-resistant fluid overload in liver disease, ...
Women with cirrhosis and ascites experience worse health-related quality of life (HRQoL) than men, although no difference is seen in daily function, according to a study published in the August issue ...
Sequana Medical AG ("Sequana Medical"), a commercial stage medical device company and an innovator in the management of liver disease & malignant ascites, announces two important developments at the ...
Use of alfapump® to control ascites enabling elective umbilical hernia repair published in Hernia Untreated umbilical hernias occur in 20% of patients with ascites due to liver cirrhosis. Without ...
There are many times when we visit a doctor for a common ache or pain, and he/she uses big and scary sounding words to tell us what we are suffering from. But that jargon often has a common and simple ...
Recurrent or refractory ascites is a severe condition characterized by the accumulation of fluid in the abdomen. The current standard treatment involves therapeutic paracentesis, an invasive and ...